In Brief: Kessler's last day
Kessler's last day: Outgoing FDA commissioner participates in White House ceremony marking the beginning of FDA tobacco regulations on Feb. 28. David Kessler, MD, is going to Yale Medical School as its dean on July 1 ("The Tan Sheet" Feb. 17, In Brief). At the Feb. 28 session of the Cosmetic, Toiletry & Fragrance Association's annual meeting, President Edward Kavanaugh introduced CTFA outside counsel Peter Barton Hutt (Covington & Burling) by noting speculation that he is a candidate to succeed Kessler. "Rumors around the last week or so have you in the final three candidates," Kavanaugh said. HHS Secretary Donna Shalala reportedly has sent a long list of candidates to the White House...
More from Archive
More from Pink Sheet
New plan to encourage alternatives to animal testing seeks interagency cooperation to meet more aggressive targets for transformational change than the US FDA’s long-standing program.
HHS Secretary Robert F. Kennedy Jr. urged FDA staff to resist the “deep state” and “crony capitalism,” and focus on improving the health of America’s children. “You're not here to take orders,” he said and urged FDA staff to speak up if they see wrongdoing.
Antabio’s next-generation, broad-spectrum antibacterial, MEM-ANT3310, has made it onto the European Medicines Agency’s priority medicines scheme. The company says its product is designed to make a significant impact on the growing problem of antimicrobial resistance.